Modulation of NF-kB Signaling by Immunoprobiotics
免疫益生菌对 NF-kB 信号传导的调节
基本信息
- 批准号:7674585
- 负责人:
- 金额:$ 45.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-01 至 2012-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffectBacteriaBacterial GenesBioreactorsCell LineCellsCoculture TechniquesComplexConditioned Culture MediaDown-RegulationEcosystemEnvironmentEpithelial CellsGene ExpressionGenesGerm-FreeGlycerolGlycerophospholipidsHelicobacter hepaticusHuman MicrobiomeImmuneImmune responseImmune systemImmunityInflammationInflammatoryInflammatory ResponseInflammatory disease of the intestineIntestinal MucosaIntestinesInvestigationLactobacillusLactobacillus reuteriMAP Kinase Signaling PathwaysMammalian CellMammalsMetabolismMicrobeMitogen-Activated Protein KinasesModelingMucous MembraneMusMutagenesisMyelogenousMyeloid CellsNF-kappa BPathway interactionsProbioticsProductionPublic HealthRegulationRelative (related person)Research PersonnelRoleSignal PathwaySignal TransductionSimulateSubgroupTestingbasecytokinegut microbiotaimmunoregulationin vivoloss of function mutationmicrobialmicrobial communitymicrobial hostmicrobiomemouse modelmutantpathogenprebioticsreconstitutionresearch studysimulationtranscription factor
项目摘要
DESCRIPTION (provided by applicant): The overall hypothesis of this proposal is that glycerol/glycerophospholipid metabolism is a focal point for determining the relative capacities of probiotics to suppress NF-?B and MAP kinase signaling in mammalian cells. Ultimately, suppression of key signaling pathways results in down-regulation of pro-inflammatory cytokine production, and selective depletion of activated immune cells. Targeted and random mutagenesis strategies will be used to generate insertion mutants of probiotics that gain or lose the ability to suppress NF-?B activation or MAP kinase signaling. Bioreactors with defined combinations of intestinal bacteria will be used in order to simulate gut bacterial ecosystems. Myeloid and epithelial cells will be combined in co-culture models in order to provide simplified models of the gut mucosa. Primary candidate immunoregulatory factors produced by lactobacilli include glycerophospholipid derivatives that may down-regulate pro-inflammatory responses. Finally, selected probiotic mutants will be introduced into a defined microbiota-containing mouse model in order to study effects of a defined microbiome on NF-?B activation and MAP kinase immune signaling pathways in vivo. These studies will occur within the context of well-characterized fluctuations of the intestinal microbiota so that microbial and host contributions to immunoregulation can be investigated in parallel using one mouse model. 1. Generate insertional mutants of immunoprobiotic Lactobacillus reuteri and identify key bacterial genes that regulate factors affecting NF-?B and MAP kinase signaling pathways. 2. Investigate regulation of NF-?B and MAP kinase signaling in a simulated gut mucosa by probiotics/mutants in the milieu of a defined microbiota. 3. Introduce wild type and isogenic probiotic mutants into IL-10-deficient mice with a defined microbiome in order to study probiotic effects on NF-?B and MAP kinase signaling pathways in vivo.
PUBLIC HEALTH REVELANCE: The investigator seeks to understand how beneficial bacteria may regulate inflammation in the intestine. This project includes a simulation of the intestinal microbial community so that investigations take place in the context of conditions similar to the complex intestinal environment. Finally, a mouse model of intestinal inflammation will be used to explore which genes of beneficial bacteria are important for regulating intestinal immune responses in mammals.
描述(由申请人提供):该提案的总体假设是甘油/甘油磷脂代谢是确定益生菌的相对能力抑制NF-?B和MAP激酶信号传导的焦点。最终,抑制关键信号通路会导致促炎性细胞因子产生的下调以及活化免疫细胞的选择性消耗。靶向和随机诱变策略将用于产生益生菌的插入突变体,这些突变体获得或失去抑制NF-?B激活或MAP激酶信号传导的能力。为了模拟肠道细菌生态系统,将使用具有定义的肠细菌组合的生物反应器。髓样细胞和上皮细胞将在共培养模型中合并,以提供肠粘膜的简化模型。乳酸杆菌产生的主要候选免疫调节因子包括可能下调促炎反应的甘油磷脂衍生物。最后,选定的益生菌突变体将被引入含微生物群的定义的小鼠模型中,以研究定义的微生物组对NF-?B激活和MAP激酶免疫信号传导途径的影响。这些研究将发生在肠道菌群的特征良好波动的背景下,因此可以使用一种小鼠模型并行研究微生物和宿主对免疫调节的贡献。 1。产生REUTERI免疫局乳杆菌的插入突变体,并鉴定关键细菌基因,以调节影响NF-?B和MAP激酶信号通路的因素。 2。研究NF-?B和MAP激酶信号传导在模拟的肠粘膜中通过益生菌/突变体在定义的微生物群的环境中调节。 3。将野生型和同生益生菌突变体引入具有定义的微生物组的IL-10缺陷小鼠,以研究对NF-?B和MAP激酶信号通路的益生菌作用。
公共卫生的启示:研究人员试图了解有益细菌如何调节肠道炎症。该项目包括对肠道微生物群落的模拟,以便在类似于复杂肠道环境的条件下进行调查。最后,将使用肠炎的小鼠模型来探索哪些有益细菌的基因对于调节哺乳动物的肠道免疫反应很重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Versalovic其他文献
James Versalovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Versalovic', 18)}}的其他基金
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
结肠肿瘤中的肠道 L-组氨酸代谢和组胺信号传导
- 批准号:
9324137 - 财政年份:2013
- 资助金额:
$ 45.84万 - 项目类别:
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
结肠肿瘤中的肠道 L-组氨酸代谢和组胺信号传导
- 批准号:
8711382 - 财政年份:2013
- 资助金额:
$ 45.84万 - 项目类别:
Gut L-Histidine Metabolism and Histamine Signaling in Colonic Neoplasia
结肠肿瘤中的肠道 L-组氨酸代谢和组胺信号传导
- 批准号:
8581697 - 财政年份:2013
- 资助金额:
$ 45.84万 - 项目类别:
INFLUENCE OF DIET ON DEVELOPMENT OF INTESTINAL MICROBIOTA
饮食对肠道菌群发育的影响
- 批准号:
8356741 - 财政年份:2010
- 资助金额:
$ 45.84万 - 项目类别:
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation
小儿腹痛和肠道炎症中的人类微生物组
- 批准号:
8128675 - 财政年份:2009
- 资助金额:
$ 45.84万 - 项目类别:
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation
小儿腹痛和肠道炎症中的人类微生物组
- 批准号:
7644815 - 财政年份:2009
- 资助金额:
$ 45.84万 - 项目类别:
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation
小儿腹痛和肠道炎症中的人类微生物组
- 批准号:
8306346 - 财政年份:2009
- 资助金额:
$ 45.84万 - 项目类别:
The Human Microbiome in Pediatric Abdominal Pain and Intestinal Inflammation
小儿腹痛和肠道炎症中的人类微生物组
- 批准号:
8111531 - 财政年份:2009
- 资助金额:
$ 45.84万 - 项目类别:
Modulation of NF-kB Signaling by Immunoprobiotics
免疫益生菌对 NF-kB 信号传导的调节
- 批准号:
7921642 - 财政年份:2008
- 资助金额:
$ 45.84万 - 项目类别:
Modulation of NF-kB Signaling by Immunoprobiotics
免疫益生菌对 NF-kB 信号传导的调节
- 批准号:
7530943 - 财政年份:2008
- 资助金额:
$ 45.84万 - 项目类别:
相似国自然基金
水平基因转移对蓝细菌基因组演化及生态适应性的影响
- 批准号:32370009
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
腐殖酸对农业土壤中抗生素抗性细菌和抗性基因的影响及机制
- 批准号:42207026
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
城市给水系统中VBNC细菌的诱导机制及其对ARGs水平基因转移的影响
- 批准号:52200004
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
海洋蓝细菌及其抑菌物质对海洋环境耐药基因产生和传播的影响研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
城市给水系统中VBNC细菌的诱导机制及其对ARGs水平基因转移的影响
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms underlying diarrhea and gut inflammation mediated by Enterotoxigenic and Enteropathogenic E. coli
产肠毒素和致病性大肠杆菌介导的腹泻和肠道炎症的机制
- 批准号:
10674072 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
- 批准号:
10648513 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Gut Microbial Factors in Farming Lifestyle and Allergic Sensitization
农业生活方式和过敏致敏中的肠道微生物因素
- 批准号:
10633368 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Using Salmonella Pathogenesis and Cell Biology as a Discovery Tool
使用沙门氏菌发病机制和细胞生物学作为发现工具
- 批准号:
10665946 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别:
Harnessing iron acquisition to hinder enterobacterial pathogenesis
利用铁的获取来阻碍肠细菌的发病机制
- 批准号:
10651432 - 财政年份:2023
- 资助金额:
$ 45.84万 - 项目类别: